These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9328015)

  • 1. Norepinephrine and schizophrenia: a new hypothesis for antipsychotic drug action.
    Breier A; Elman I; Goldstein DS
    Adv Pharmacol; 1998; 42():785-8. PubMed ID: 9328015
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol.
    Brown AS; Gewirtz G; Harkavy-Friedman J; Cooper T; Brébion G; Amador XF; Malaspina D; Gorman JM
    Neuropsychopharmacology; 1997 Nov; 17(5):317-25. PubMed ID: 9348547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of clozapine partial responders with conventional antipsychotics.
    Rajarethinam R; Gilani S; Tancer M; DeQuardo J
    Schizophr Res; 2003 Mar; 60(1):97-8. PubMed ID: 12505145
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlated changes in symptoms and neurotransmitter indices during maintenance treatment with clozapine or conventional neuroleptics in adolescents and young adults with schizophrenia.
    Schulz E; Fleischhaker C; Remschmidt HE
    J Child Adolesc Psychopharmacol; 1996; 6(2):119-31. PubMed ID: 9231304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine.
    Pickar D; Owen RR; Litman RE; Konicki E; Gutierrez R; Rapaport MH
    Arch Gen Psychiatry; 1992 May; 49(5):345-53. PubMed ID: 1375019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical variables in schizophrenic patients during switching from neuroleptics to clozapine.
    Hatzimanolis J; Lykouras L; Markianos M; Oulis P
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1077-85. PubMed ID: 9829289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomic effects of clozapine in schizophrenia: comparison with placebo and fluphenazine.
    Zahn TP; Pickar D
    Biol Psychiatry; 1993 Jul 1-15; 34(1-2):3-12. PubMed ID: 8104043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task.
    Cohen RM; Nordahl TE; Semple WE; Andreason P; Litman RE; Pickar D
    Arch Gen Psychiatry; 1997 May; 54(5):481-6. PubMed ID: 9152102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of peripheral noradrenergic stimulation by clozapine.
    Elman I; Goldstein DS; Eisenhofer G; Folio J; Malhotra AK; Adler CM; Pickar D; Breier A
    Neuropsychopharmacology; 1999 Jan; 20(1):29-34. PubMed ID: 9885782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness.
    Rapaport MH; McAllister CG; Kirch DG; Pickar D
    Biol Psychiatry; 1991 Apr; 29(7):715-7. PubMed ID: 1711382
    [No Abstract]   [Full Text] [Related]  

  • 11. Clozapine as a first treatment for schizophrenia.
    Woerner MG; Robinson DG; Alvir JM; Sheitman BB; Lieberman JA; Kane JM
    Am J Psychiatry; 2003 Aug; 160(8):1514-6. PubMed ID: 12900316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of clozapine response in schizophrenia.
    Pickar D; Owen RR; Litman RE; Hsiao JK; Su TP
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():129-32. PubMed ID: 7525541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of clozapine on biogenic amines within the scope of drug treatment of schizophrenic psychoses in adolescence].
    Schulz E; Remschmidt H; Fleischhaker C
    Z Kinder Jugendpsychiatr; 1994 Dec; 22(4):285-98. PubMed ID: 7856324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biogenic amines as predictors of response to clozapine treatment in early-onset schizophrenia.
    Fleischhaker C; Schulz E; Remschmidt H
    J Psychiatr Res; 1998; 32(5):325-33. PubMed ID: 9789212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine. A novel antipsychotic agent.
    Baldessarini RJ; Frankenburg FR
    N Engl J Med; 1991 Mar; 324(11):746-54. PubMed ID: 1671793
    [No Abstract]   [Full Text] [Related]  

  • 16. High-dose olanzapine for treatment-resistant schizophrenia.
    Roth BL
    J Clin Psychiatry; 2008 Feb; 69(2):176-7. PubMed ID: 18363451
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA-A2 and B35 are strong predictors of responsiveness to clozapine: preliminary data in Italian schizophrenia patients.
    Marchini M; Scorza R; Antonioli R; Scarone S; Grassi B; Epifani M; Dragoni C
    Schizophr Res; 2001 Mar; 48(2-3):363-5. PubMed ID: 11368031
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dopamine D4-receptor variants, schizophrenia and clozapine therapy].
    Ewald HL; Mors NP; Rosenberg R
    Ugeskr Laeger; 1996 Jun; 158(25):3601-3. PubMed ID: 8693618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated clozapine serum level after treatment with amiodarone.
    Stevens JR; Freudenreich O; Stern TA
    Psychosomatics; 2008; 49(3):255-7. PubMed ID: 18448783
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary on "clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia." Psychopharmacology (1989) 99:S18-S27.
    Meltzer HY
    Psychopharmacology (Berl); 2002 Aug; 163(1):1-3. PubMed ID: 12185394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.